MaxCyte, Inc.

MXCT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$41,055-$37,923-$23,571-$19,082
Dep. & Amort.$4,315$4,566$2,698$1,424
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$13,979$0$7,959
Change in WC-$751$3,820-$3,211-$1,645
Other Non-Cash$9,881-$6,128$9,301$665
Operating Cash Flow-$27,610-$21,686-$14,783-$10,680
Investing Activities
PP&E Inv.-$1,651-$3,700-$18,477-$3,834
Net Acquisitions$0$0$0$0
Inv. Purchases-$150,857-$255,095-$290,942-$268,684
Inv. Sales/Matur.$159,440$313,770$284,596$77,500
Other Inv. Act.$0$9$0$5
Investing Cash Flow$6,932$54,984-$24,823-$195,013
Financing Activities
Debt Repay.$0$0$0-$4,989
Stock Issued$2,056$269$2,889$236,077
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$1,874$0$3,631
Financing Cash Flow$2,056$2,143$2,889$234,720
Forex Effect$0$0$0$0
Net Chg. in Cash-$18,622$35,441-$36,718$29,027
Supplemental Information
Beg. Cash$46,506$11,065$47,782$18,755
End Cash$27,884$46,506$11,065$47,782
Free Cash Flow-$29,261-$25,386-$33,260-$14,514